Clinical Trials Browser

OTHER_GOV × Interventional × ibritumomab tiuxetan × Clear all

NCT00491491 2020-08-31

Zevalin-beam for Aggressive Lymphoma

Phase 3 Completed

60 enrolled 12 charts

Lymphoma, Non-Hodgkin